Metabolic Acidosis in Patients with Neobladders

Patients who undergo neobladder formation following radical cystectomy or cystoprostatectomy may experience hyperchloraemic metabolic acidosis, which is a documented complication. This condition is usually mild and improves over time, but severe and persistent metabolic acidosis may occur when patients undergo further surgery for other reasons. Medical staff treating patients with neobladders should be aware of this complication and treat it with intravenous fluids and bicarbonate. Hypokalemia, hypocalcaemia, and hypomagnesaemia may also be present as associated electrolyte abnormalities.

In a patient with hyperchloraemic metabolic acidosis, there is also a mild hypernatraemia and hypokalaemia. Lactate concentrations are normal, indicating that the acidosis is not due to organ hypoperfusion. Potassium depletion can be exacerbated by the correction of acidosis, and potassium supplementation alone via a central venous catheter is not sufficient treatment. Rehydration with 0.9% N. saline may worsen the hyperchloraemic state. Breathing into a paper bag is not appropriate treatment for this patient, as they have hyperglycaemia secondary to the metabolic stress response and not ketoacidosis.

Pleural effusion is a condition where fluid accumulates in the pleural space, the area between the lungs and the chest wall. To investigate this condition, the British Thoracic Society (BTS) recommends performing a posterioranterior (PA) chest x-ray and an ultrasound to increase the likelihood of successful pleural aspiration and detect pleural fluid septations. Contrast CT is also increasingly used to investigate the underlying cause, particularly for exudative effusions. Pleural aspiration should be performed using a 21G needle and 50ml syringe, and the fluid should be sent for pH, protein, lactate dehydrogenase (LDH), cytology, and microbiology. Light’s criteria can be used to distinguish between a transudate and an exudate, and other characteristic pleural fluid findings can help identify the underlying cause.

In cases of pleural infection, diagnostic pleural fluid sampling is required for all patients with a pleural effusion in association with sepsis or a pneumonic illness. If the fluid is purulent or turbid/cloudy, a chest tube should be placed to allow drainage. If the fluid is clear but the pH is less than 7.2 in patients with suspected pleural infection, a chest tube should also be placed.

For patients with recurrent pleural effusions, options for management include recurrent aspiration, pleurodesis, indwelling pleural catheter, and drug management to alleviate symptoms such as dyspnea. It is important to follow the BTS guidelines for investigation and management of pleural effusion to ensure appropriate diagnosis and treatment.

Understanding Hereditary Sensorimotor Neuropathy (HSMN)

Hereditary sensorimotor neuropathy (HSMN) is a term used to describe Charcot-Marie-Tooth disease, also known as peroneal muscular atrophy. This condition has been classified into over seven types, but only two are commonly seen in clinical practice. HSMN type I is an autosomal dominant condition that primarily affects the myelin, due to a defect in the PMP-22 gene. Symptoms often begin during puberty and are characterized by distal muscle wasting, clawed toes, pes cavus, foot drop, and leg weakness. Motor symptoms are more prominent in this type of HSMN.

To summarize, HSMN is a genetic condition that affects the peripheral nerves, leading to muscle weakness and wasting. HSMN type I is the most common type and is caused by a defect in the PMP-22 gene, which affects the myelin. This type of HSMN primarily affects motor function and often presents with foot drop, leg weakness, and distal muscle wasting. Understanding the different types of HSMN can help with early diagnosis and management of symptoms.

Causes of Iron and B12 Deficiency

Iron deficiency and B12 deficiency can be caused by various factors. One possible cause is partial gastrectomy, which can reduce the absorption of both iron and B12. Gastric acid helps in the absorption of iron, and without it, iron absorption is reduced. Vitamin B12 is absorbed in the terminal ileum with the help of intrinsic factor, which is produced by gastric parietal cells. Partial gastrectomy can significantly reduce intrinsic factor production, leading to B12 deficiency.

However, pancreaticoduodenectomy is not a cause of iron and B12 deficiency. It is performed for resectable pancreatic or ampulla of Vater carcinomas, not for severe upper GI haemorrhage. Hemicolectomy does not significantly impact the absorption of B12 or ferritin. Terminal ileal resection can lead to B12 deficiency and bile salt malabsorption, but it should not cause significant iron deficiency. Emergency splenectomy is performed for trauma and is not associated with B12 or iron deficiency.

Understanding Neutropenic Sepsis in Cancer Patients

Neutropenic sepsis is a common complication that arises from cancer therapy, particularly chemotherapy. It typically occurs within 7-14 days after chemotherapy and is characterized by a neutrophil count of less than 0.5 * 109 in patients undergoing anticancer treatment who exhibit a temperature higher than 38ºC or other signs of clinically significant sepsis. To prevent this condition, patients who are likely to have a neutrophil count of less than 0.5 * 109 should be offered a fluoroquinolone.

Immediate antibiotic therapy is crucial in managing neutropenic sepsis. It is recommended to start empirical antibiotic therapy with piperacillin with tazobactam (Tazocin) without waiting for the WBC. While some units add vancomycin if the patient has central venous access, NICE does not support this approach. After the initial treatment, patients are assessed by a specialist and risk-stratified to determine if they can receive outpatient treatment. If patients remain febrile and unwell after 48 hours, an alternative antibiotic such as meropenem may be prescribed, with or without vancomycin. If patients do not respond after 4-6 days, the Christie guidelines suggest ordering investigations for fungal infections (e.g. HRCT) instead of blindly starting antifungal therapy. In selected patients, G-CSF may also be considered.

The echocardiogram is the appropriate test to monitor for potential cardiac complications associated with cabergoline, a dopaminergic drug used to treat Parkinson’s disease. While this drug can lead to fibrotic reactions in various parts of the body, it is also known to cause valvulopathy. The British National Formulary recommends establishing a baseline set of investigations and then monitoring for symptoms such as dyspnoea, persistent cough, chest pain, cardiac failure, and abdominal pain or tenderness.

Dopamine Receptor Agonists for Parkinson’s Disease and Other Conditions

Dopamine receptor agonists are medications used to treat Parkinson’s disease, prolactinoma/galactorrhoea, cyclical breast disease, and acromegaly. In Parkinson’s disease, treatment is typically delayed until the onset of disabling symptoms, at which point a dopamine receptor agonist is introduced. Elderly patients may be given L-dopa as an initial treatment. Examples of dopamine receptor agonists include bromocriptine, ropinirole, cabergoline, and apomorphine.

However, some dopamine receptor agonists, such as bromocriptine, cabergoline, and pergolide, which are ergot-derived, have been associated with pulmonary, retroperitoneal, and cardiac fibrosis. Therefore, the Committee on Safety of Medicines recommends obtaining an ESR, creatinine, and chest x-ray before treatment and closely monitoring patients. Pergolide was even withdrawn from the US market in March 2007 due to concerns about an increased incidence of valvular dysfunction.

Despite their effectiveness, dopamine receptor agonists can cause adverse effects such as nausea/vomiting, postural hypotension, hallucinations, and daytime somnolence. Therefore, patients taking these medications should be closely monitored for any adverse effects.

Indications for Surgery in Native Infective Endocarditis

Native infective endocarditis is a serious condition that can lead to severe complications if left untreated. According to the European Society of Cardiology, surgery may be necessary in certain cases. These cases include aortic or mitral infective endocarditis with severe regurgitation, valve obstruction, fistula into a cardiac chamber or pericardium causing refractory pulmonary oedema or cardiogenic shock. Surgery may also be necessary in cases of aortic or mitral infective endocarditis with severe acute regurgitation and persisting heart failure or echocardiographic signs of poor haemodynamic tolerance (early mitral closure or pulmonary hypertension).

In addition, surgery may be necessary in cases of locally uncontrolled infection, persistent fever and positive blood culture more than 7-10 days, and infection caused by fungi or multiresistant organisms. It is important to note that surgery is not always necessary in cases of native infective endocarditis, and treatment will depend on the individual case and the severity of the condition.

Arthropathy in Hereditary Haemochromatosis

Hereditary haemochromatosis is a condition that should be suspected in patients with liver cirrhosis, diabetes mellitus, hypogonadism and impotence, skin hyperpigmentation, fatigue and arthropathy. The arthropathy in hereditary haemochromatosis is due to calcium pyrophosphate crystal deposition and can include pseudo-gout, chondrocalcinosis and chronic arthropathy. Biochemical findings include high serum iron, ferritin and transferrin saturation, and liver biopsy shows staining for excess iron.

Cystinosis is a metabolic disease that causes end-stage renal function due to the accumulation of cysteine. Osteomalacia is often asymptomatic and bilateral knee joint pain is not a common presentation. Ochronosis describes the pigment deposition that occurs in the connective tissues of patients with alkaptonuria, which is not associated with the bronze appearance of the skin in this patient. Gout would present with hot, tender, swollen joints and subcortical bone cysts, but bilateral knee involvement would be unusual. Monosodium urate crystal deposition is not associated with hereditary haemochromatosis.

For a patient with a 1.5cm left-sided pneumothorax and a history of COPD, the management depends on the type of pneumothorax. In this case, it is likely a secondary pneumothorax. If the patient is aged >50 years with a rim of air >2cm or clinically short of breath, a chest drain should be inserted as first-line treatment. Although the pneumothorax is <2cm, this patient is clinically short of breath, making a chest drain the most appropriate management. Nebulised salbutamol is not indicated as there is no auscultatory wheeze to suggest an exacerbation. Non-invasive ventilation is contraindicated as it can convert a simple pneumothorax into a tension pneumothorax. A CT chest may be useful to identify blebs that may give rise to a pneumothorax, but it will not change the immediate management. Needle decompression is not indicated as the patient does not show signs of tension pneumothorax. Pneumothorax, a condition where air enters the space between the lung and chest wall, can be managed according to guidelines published by the British Thoracic Society (BTS) in 2010. The guidelines differentiate between primary pneumothorax, which occurs without underlying lung disease, and secondary pneumothorax, which does have an underlying cause. For primary pneumothorax, patients with a small amount of air and no shortness of breath may be discharged, while those with larger amounts of air or shortness of breath may require aspiration or chest drain insertion. For secondary pneumothorax, chest drain insertion is recommended for patients over 50 years old with large amounts of air or shortness of breath, while aspiration may be attempted for those with smaller amounts of air. Patients with persistent or recurrent pneumothorax may require video-assisted thoracoscopic surgery. Discharge advice includes avoiding smoking to reduce the risk of further episodes and avoiding scuba diving unless the patient has undergone surgery and has normal lung function.

The individual in question is suffering from African trypanosomiasis, also known as sleeping sickness. Based on their symptoms and country of origin, it is likely that they have contracted the East African variant caused by Trypanosoma brucei rhodesiense. While it is possible to detect the presence of the parasites in a peripheral blood film or lymph node biopsy, the most important factor in determining treatment options is whether or not the parasites have invaded the central nervous system (CNS). Treatment for early infection typically involves the use of pentamidine, while options for CNS infection include suramin, melarsoprol, eflornithine, and nifurtimox. These medications are not widely available and can cause severe side effects, so they are typically only prescribed by specialists in tropical medicine.

Understanding Trypanosomiasis

Trypanosomiasis is a protozoal disease that comes in two main forms: African trypanosomiasis, also known as sleeping sickness, and American trypanosomiasis, or Chagas’ disease. The former has two types: Trypanosoma gambiense in West Africa and Trypanosoma rhodesiense in East Africa, both of which are spread by the tsetse fly. Trypanosoma rhodesiense tends to have a more acute course. Symptoms include a painless subcutaneous nodule at the site of infection, intermittent fever, enlargement of posterior cervical lymph nodes, and later, central nervous system involvement such as somnolence, headaches, mood changes, and meningoencephalitis.

On the other hand, American trypanosomiasis is caused by the protozoan Trypanosoma cruzi. In the acute phase, the vast majority of patients (95%) are asymptomatic, although a chagoma (an erythematous nodule at the site of infection) and periorbital oedema are sometimes seen. Chronic Chagas’ disease mainly affects the heart and gastrointestinal tract, with myocarditis leading to dilated cardiomyopathy (with apical atrophy) and arrhythmias, and gastrointestinal features including megaoesophagus and megacolon causing dysphagia and constipation.

Early disease management for African trypanosomiasis involves IV pentamidine or suramin, while later disease or central nervous system involvement requires IV melarsoprol. Treatment for American trypanosomiasis is most effective in the acute phase using azole or nitroderivatives such as benznidazole or nifurtimox. Chronic disease management involves treating the complications, such as heart failure.

The case describes a patient with acute graft versus host disease (GVHD) post bone marrow transplant. The patient has multi-system involvement, including skin rash, raised bilirubin, and abnormal colored diarrhea. The full blood count is normal for a patient post BMT, ruling out other potential causes such as CMV infection or cyclosporin toxicity. Transfusion-associated GVHD is a rare but fatal complication that occurs when donor lymphocytes in transfused blood components recognize the recipient as foreign and cause bone marrow failure, liver dysfunction, and gastrointestinal symptoms. However, the FBC result and timing do not support this diagnosis.

Colorectal cancer is often associated with Streptococcus bovis endocarditis.

Streptococcus gallolyticus is a specific type of Streptococcus bovis. When patients present with Streptococcus bovis bacteraemia, it is important to investigate for underlying colonic malignancies as approximately 10 to 25 percent of cases are associated with this condition. The most reliable investigation for this is a colonoscopy.

If a malignancy is detected during colonoscopy, a CT scan of the chest, abdomen, and pelvis may be necessary to check for metastases. However, this imaging technique is not as effective as colonoscopy in detecting colonic malignancies. Similarly, an ultrasound of the abdomen is also less sensitive than colonoscopy for diagnosing colonic malignancies.

Aetiology of Infective Endocarditis

Infective endocarditis is a condition that affects patients with previously normal valves, rheumatic valve disease, prosthetic valves, congenital heart defects, intravenous drug users, and those who have recently undergone piercings. The strongest risk factor for developing infective endocarditis is a previous episode of the condition. The mitral valve is the most commonly affected valve.

The most common cause of infective endocarditis is Staphylococcus aureus, particularly in acute presentations and intravenous drug users. Historically, Streptococcus viridans was the most common cause, but this is no longer the case except in developing countries. Coagulase-negative Staphylococci such as Staphylococcus epidermidis are commonly found in indwelling lines and are the most common cause of endocarditis in patients following prosthetic valve surgery. Streptococcus bovis is associated with colorectal cancer, with the subtype Streptococcus gallolyticus being most linked to the condition.

Culture negative causes of infective endocarditis include prior antibiotic therapy, Coxiella burnetii, Bartonella, Brucella, and HACEK organisms (Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, Kingella). It is important to note that systemic lupus erythematosus and malignancy, specifically marantic endocarditis, can also cause non-infective endocarditis.

Management of Salicylate Poisoning

The clinical presentation of a patient with salicylate poisoning is indicative of a moderate overdose of aspirin. Unfortunately, there is no specific antidote for salicylate ingestion. Therefore, the management of this type of poisoning is supportive, with measures aimed at preventing further absorption from the gastrointestinal tract and enhancing excretion.

The initial treatment for salicylate poisoning should involve the administration of activated charcoal, which should be repeated as necessary to prevent delayed absorption of salicylate. Gastric lavage may be useful if the ingestion occurred within one hour, but airway protection is essential during the procedure. Afterward, the patient should be rehydrated, and their urine should be alkalinized to promote urinary excretion. This can be achieved by administering an infusion of sodium bicarbonate. The goal is to increase the ionization of salicylic acid, a weak acid, in an alkaline environment, which will increase its excretion tenfold.

Forced diuresis alone is not recommended as it can lead to severe electrolyte imbalances and pulmonary or cerebral edema. In severe cases of salicylate poisoning, such as those with high plasma levels of salicylate (>800 mg/L), severe metabolic acidosis, acute kidney injury, or neurological impairment (coma, hallucinations, or seizures), early hemodialysis may be necessary. Overall, the management of salicylate poisoning requires a comprehensive approach that includes supportive care, prevention of further absorption, and enhanced excretion.

Myocardial Rupture and Pericardial Effusion Following Pacemaker Insertion

The presenting symptoms suggest that the patient has experienced myocardial rupture, most likely ventricular, resulting in a pericardial effusion. This condition is causing hemodynamic compromise, and urgent intervention with pericardiocentesis is necessary to prevent cardiac tamponade. Myocardial rupture is a rare complication (<1%) that can occur either early or late after the procedure. Delayed perforations are less likely to cause acute symptoms and have a lower incidence of tamponade and sudden cardiac death. Risk factors for perforation include physician technique, patient factors (such as obesity or difficult anatomy), and lead design. A pulmonary embolism (PE) is unlikely to be the cause of the X-ray findings, and the patient has no additional risk factors for PE other than obesity. Similarly, pneumothorax and acute respiratory distress syndrome (ARDS) are unlikely to be the cause of the patient’s symptoms. Symptoms of superior vena cava (SVC) obstruction would present differently and would not likely occur so acutely after the procedure. In cases of SVC obstruction, patients typically experience neck and facial swelling with visible collateral veins on the chest and neck. For further reading on pacemaker complications, including lead and pocket complications, and left ventricular free wall rupture, please refer to the following resources:
– Common Pacemaker Problems: Lead and Pocket Complications
– Complications and lead extraction in cardiac pacing and defibrillation
– Left ventricular free wall rupture: clinical presentation and management

Scabies: Causes, Symptoms, and Treatment

Scabies is a skin infestation caused by Sarcoptes scabiei, which often occurs in outbreaks in institutions like nursing homes and schools. The female mite burrows into the skin and leaves behind a trail of about 40 eggs after fertilization. This infestation causes intense itching, usually in the folds of skin between the fingers, flexor wrist surfaces, the abdomen, and thighs.

To diagnose scabies, doctors examine the mite, its feces, or eggs under a microscope. Treatment for scabies involves the use of malathion 0.5% liquid, which requires the entire household to undergo treatment. Scabies is a highly contagious condition, and it is essential to treat all members of the household to prevent reinfestation.

In summary, scabies is a skin infestation caused by a mite that burrows into the skin and leaves behind eggs. It causes intense itching and is highly contagious. Treatment involves the use of malathion 0.5% liquid, and all members of the household must undergo treatment to prevent reinfestation.

Pancoast Tumour: A Localised Lung Cancer

A Pancoast tumour, also known as a superior sulcus tumour, is a type of lung cancer that develops in the uppermost part of the lung. This cancerous growth infiltrates the surrounding tissues, including the brachial plexus, ribs, and mediastinum. Patients with this condition often exhibit signs of local extension, such as neurological symptoms in the arm and hand, Horner’s syndrome on the same side as the tumour, or rib destruction visible on radiological scans.

A CT scan is the preferred diagnostic tool for detecting a Pancoast tumour. However, obtaining biopsy material can be challenging due to the tumour’s location. Bronchoscopy is not useful in this case as the lesion is too peripheral. Squamous cell carcinoma is the most common type of tumour found in patients with Pancoast tumours. Unfortunately, these tumours are often inoperable when diagnosed.

Overall, a Pancoast tumour is a localised lung cancer that can cause significant symptoms due to its proximity to surrounding tissues. Early detection and treatment are crucial for improving patient outcomes.

The presence of H.pylori antibodies in a patient’s serology can indicate prior exposure to Helicobacter pylori, but it is linked to symptoms in the upper gastrointestinal tract.

Faecal Calprotectin: A Screening Tool for Intestinal Inflammation

Faecal calprotectin is a recommended screening tool for inflammatory bowel disease (IBD) by NICE. It is a test that detects intestinal inflammation and can also be used to monitor the response to treatment in IBD patients. The test has a high sensitivity of 93% and specificity of 96% for IBD in adults. However, in children, the specificity falls to around 75%.

Apart from IBD, other conditions that can cause a raised faecal calprotectin include bowel malignancy, coeliac disease, infectious colitis, and the use of NSAIDs. Therefore, faecal calprotectin is a useful diagnostic tool for detecting intestinal inflammation and can aid in the diagnosis and management of various gastrointestinal conditions.

Effects of Body Temperature on Electrolyte Balance

As the body temperature increases, it can lead to hyperthermia and heatstroke. One of the earliest abnormalities that can occur is hypokalaemia, which is caused by an increase in potassium uptake by muscles due to the stimulation of the NA-K-ATPase transporter by catecholamines. However, as the body temperature continues to rise, hyperkalaemia can develop, along with rhabdomyolysis and lactic acidosis. Severe cases may also show elevated levels of CSF lactate. The acid-base balance in such cases is characterized by metabolic acidosis with compensatory respiratory alkalosis.

Similar to dehydration states, the body tries to conserve water by concentrating urine, resulting in high urine osmolality. It is important to monitor electrolyte levels in cases of hyperthermia to prevent complications and ensure proper treatment.

Idiopathic Intracranial Hypertension (IIH)

Idiopathic intracranial hypertension (IIH), previously known as benign intracranial hypertension or pseudotumour cerebri, is a condition that primarily affects young to middle-aged females with a high BMI. The use of certain medications, such as oral contraceptives, corticosteroids, tetracyclines, and vitamin A, has been linked to an increased likelihood of developing IIH.

Symptoms of IIH include frontal headaches that worsen when lying flat, coughing, bending, and upon waking, as well as nausea, vomiting, and a whooshing sound in the ears. Patients may also experience pain, numbness, or tingling in their arms and legs, as well as transient, bilateral episodes of blurred vision, transient visual field defects, and double vision.

While raised intracranial pressure and bilateral optic disc swelling can be seen with other conditions such as intracranial aneurysms, intracranial tumors, and subdural hematomas, the patient’s profile and medication history make IIH the most likely diagnosis. Migraine could cause similar symptoms, but it would not explain the bilateral optic disc swelling.

Chronic use of paracetamol can result in a raised anion gap metabolic acidosis due to 5-oxoproline.

To determine if a patient has a raised anion gap metabolic acidosis, the MUDPILES acronym can be used to identify potential causes. This includes methanol, uremia, diabetic ketoacidosis, paracetamol use (chronic), isoniazid, lactate, ethanol or propylene glycol, and salicylates.

To calculate the anion gap, the formula [Na (145) + K (5)] – [Cl (95) + HCO3 (15)] can be used. A normal anion gap falls between 8-16 mmol/L.

In this case, the patient has a raised anion gap metabolic acidosis with a value of 40 mmol/L. Of the options provided, only chronic paracetamol use can cause this condition.

Addison’s disease, diarrhea, type 1 renal tubular acidosis, and type 2 renal tubular acidosis all result in a normal anion gap metabolic acidosis and are therefore not the correct answer.

Understanding Anion Gap in Metabolic Acidosis

Metabolic acidosis is a condition where the body produces too much acid or loses too much bicarbonate. Anion gap is a useful tool in diagnosing metabolic acidosis. It is calculated by subtracting the sum of bicarbonate and chloride from the sum of sodium and potassium. A normal anion gap is between 8-14 mmol/L.

There are two types of metabolic acidosis: normal anion gap and raised anion gap. Normal anion gap or hyperchloraemic metabolic acidosis can be caused by gastrointestinal bicarbonate loss, renal tubular acidosis, drugs like acetazolamide, ammonium chloride injection, and Addison’s disease. On the other hand, raised anion gap metabolic acidosis can be caused by lactate due to shock or hypoxia, ketones in diabetic ketoacidosis or alcohol, urate in renal failure, acid poisoning from salicylates or methanol, and 5-oxoproline from chronic paracetamol use.

Understanding anion gap in metabolic acidosis is crucial in identifying the underlying cause of the condition. It helps healthcare professionals in providing appropriate treatment and management to patients.

The recommended initial management for acute pericarditis involves a combination of NSAIDs and colchicine, according to the current guidelines from the European Society of Cardiology. In this case, the patient’s history, examination, and blood tests suggest acute pericarditis/myopericarditis, with the high troponin levels indicating myocardial injury likely caused by myopericarditis. While the patient’s smoking history increases their risk for a coronary event, the evidence points towards pericarditis as the primary issue. It is important to note that a dynamic rise in troponin levels is not observed.

Acute Pericarditis: Causes, Features, Investigations, and Management

Acute pericarditis is a possible diagnosis for patients presenting with chest pain. The condition is characterized by chest pain, which may be pleuritic and relieved by sitting forwards. Other symptoms include non-productive cough, dyspnoea, and flu-like symptoms. Tachypnoea and tachycardia may also be present, along with a pericardial rub.

The causes of acute pericarditis include viral infections, tuberculosis, uraemia, trauma, post-myocardial infarction, Dressler’s syndrome, connective tissue disease, hypothyroidism, and malignancy.

Investigations for acute pericarditis include ECG changes, which are often global/widespread, as opposed to the ‘territories’ seen in ischaemic events. The ECG may show ‘saddle-shaped’ ST elevation and PR depression, which is the most specific ECG marker for pericarditis. All patients with suspected acute pericarditis should have transthoracic echocardiography.

Management of acute pericarditis involves treating the underlying cause. A combination of NSAIDs and colchicine is now generally used as first-line treatment for patients with acute idiopathic or viral pericarditis.

In summary, acute pericarditis is a possible diagnosis for patients presenting with chest pain. The condition is characterized by chest pain, which may be pleuritic and relieved by sitting forwards, along with other symptoms. The causes of acute pericarditis are varied, and investigations include ECG changes and transthoracic echocardiography. Management involves treating the underlying cause and using a combination of NSAIDs and colchicine as first-line treatment.

Understanding Post-Exposure Prophylaxis for Rabies

Rabies is a viral infection that can be transmitted through the bite of an infected mammal. If a person is bitten by an animal that may have rabies, they should seek medical attention immediately. The appropriate post-exposure prophylaxis (PEP) will depend on the patient’s vaccination history and the severity of the bite.

If the patient has been previously vaccinated against rabies, they will only need vaccination on the day of the bite and three days later to establish immunity. However, if the patient has not been vaccinated before, PEP should include both passive (immunoglobulin) and active (vaccination) immunisation. In this case, the patient would receive IV rabies immunoglobulin (RIG) and vaccination on days 0, 3, 7, 14, and 30.

If the patient has not been vaccinated before and presents within a week of the bite, they would receive the full treatment, which includes IV RIG and vaccination on days 0, 3, 7, 14, and 30. However, if the patient presents after a week, IV immunoglobulins are not likely to be effective.

In summary, PEP for rabies should be tailored to the patient’s vaccination history and the severity of the bite. It is important to seek medical attention immediately after a potential exposure to rabies to ensure appropriate treatment.

Prognostic Factors in Acute Myeloid Leukaemia

Acute myeloid leukaemia (AML) is a type of blood cancer that can be influenced by various prognostic factors. One of the unfavourable abnormalities associated with AML is the deletion of part of chromosome 5 (5q–), along with other complex translocations and additions. However, favourable karyotype abnormalities such as translocation t(8;21) can also occur. Age is another factor that affects prognosis, with survival rates decreasing significantly after age 40. Thrombocytopenia, or low platelet count, is common in AML but does not significantly impact prognosis compared to other factors such as renal impairment, performance status, prior haematological malignancy, and karyotype abnormalities. Overall, understanding these prognostic factors can help guide treatment decisions and improve outcomes for patients with AML.

The clinical scenario presented suggests a myoneuropathy, most likely caused by colchicine. This drug can lead to subacute proximal muscle weakness and, in some cases, acute necrotising myopathy. Creatine phosphokinase levels may be normal or elevated, and metabolic myopathies should be ruled out if levels are normal. Muscle biopsy may show elements of both myopathic and neuropathic disease, with special features including rimmed vacuoles in muscle fibres on Gomori staining. The mechanism behind this is not fully understood, but it is believed to be due to the drug’s interference with tubulin, a protein required for the polymerisation of microtubules in muscle and nerve tissues. While weakness resolves when the drug is discontinued, neuropathic features may remain. Other potential causes, such as thyroid myopathy, limb girdle muscular dystrophy, and multiple sclerosis, can be ruled out based on the absence of certain symptoms and signs. Perindopril is not a known cause of myopathy or neuropathy and is therefore not responsible for the presented symptoms.

Mepolizumab is a suitable treatment option for asthma patients with high eosinophils. This anti-IL5 monoclonal antibody works by binding to IL5 and preventing it from promoting eosinophil growth and activity. Studies have shown that mepolizumab can significantly improve symptoms in patients with resistant asthma. Omalizumab, on the other hand, is an anti-IgE monoclonal antibody that is effective in treating resistant asthma with raised IgE and allergic symptoms. Mycophenolate is not used for resistant asthma, but rather for lupus nephritis and as an anti-rejection agent. Infliximab is used for inflammatory bowel disease and arthritides, while tiotropium is primarily used for COPD. Nebulisers are only used for asthma patients who cannot use a conventional inhaler and spacer device for beta agonist therapy.

Respiratory medicine utilizes various drugs to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Salbutamol is a short-acting inhaled bronchodilator that relaxes bronchial smooth muscle through its effects on beta 2 receptors. It is commonly used in asthma and COPD treatment. Salmeterol, a long-acting beta receptor agonist, has similar effects. Corticosteroids are anti-inflammatory drugs used as maintenance therapy in the form of inhaled corticosteroids. Oral or intravenous corticosteroids are used following an acute exacerbation of asthma or COPD.

Ipratropium is a short-acting inhaled bronchodilator that blocks muscarinic acetylcholine receptors, relaxing bronchial smooth muscle. It is primarily used in COPD treatment, while tiotropium has similar effects but is long-acting. Methylxanthines, such as theophylline, are non-specific inhibitors of phosphodiesterase, resulting in an increase in cAMP. They are given orally or intravenously and have a narrow therapeutic index. Monteleukast and zafirlukast block leukotriene receptors and are usually taken orally. They are useful in treating aspirin-induced asthma. Overall, these drugs play a crucial role in managing respiratory conditions and improving patients’ quality of life.

European Society of Cardiology’s Recommendations for Cardiac Device Related Infective Endocarditis

The European Society of Cardiology has issued guidelines for the management of infective endocarditis related to cardiac devices. According to these guidelines, patients with cardiac device related infective endocarditis should undergo urgent extraction of the implanted device followed by prolonged antibiotic therapy. Even patients with large vegetations (>10mm) should undergo percutaneous extraction. After device removal, the need for reimplantation should be reassessed. Additionally, routine antibiotic prophylaxis is recommended before device implantation.

In summary, the European Society of Cardiology recommends a comprehensive approach to the management of infective endocarditis related to cardiac devices. This includes prompt device removal, prolonged antibiotic therapy, and reassessment of the need for reimplantation. These guidelines aim to improve patient outcomes and reduce the risk of complications associated with cardiac device related infective endocarditis.

Common Causes of Mild Hypertriglyceridaemia

Mild hypertriglyceridaemia, or elevated levels of triglycerides in the blood, is commonly caused by obesity. This is due to a decrease in the effectiveness of lipoprotein lipase activity and an increase in the production of very low-density lipoprotein (VLDL). In the UK, approximately 20% of individuals are considered obese, and this number is on the rise. Alcohol consumption is also a significant contributor to hypertriglyceridaemia.

Aside from obesity and alcohol, there are other secondary causes of mild hypertriglyceridaemia. These include pregnancy, hypothyroidism, the use of diuretics, and pancreatitis. It is important to identify the underlying cause of hypertriglyceridaemia in order to properly manage and treat the condition.

Understanding Zinc Deficiency and Acrodermatitis Enteropathica

Zinc deficiency is a condition that can lead to a range of symptoms, including acrodermatitis, which is characterized by red, crusted lesions that appear in an acral distribution, peri-orificial, perianal, and alopecia. Other symptoms of zinc deficiency include short stature, hypogonadism, hepatosplenomegaly, geophagia (ingesting clay/soil), and cognitive impairment.

One specific form of zinc deficiency is known as acrodermatitis enteropathica, which is a recessively inherited partial defect in intestinal zinc absorption. This condition can lead to a range of symptoms, including skin lesions, diarrhea, and other gastrointestinal issues. Treatment may involve zinc supplementation and dietary changes to ensure adequate zinc intake.

Next Steps in Hypertension Management

When it comes to managing hypertension, non-pharmacological measures should always be the first line of defense. In the case of a patient who has already reduced their salt intake, the next step should not be to prescribe an angiotensin-converting enzyme (ACE) inhibitor. Instead, the patient should focus on reducing their alcohol intake. This is a crucial step in managing hypertension and can have a significant impact on blood pressure levels.

While reassurance may be helpful in some cases, it is unlikely to bring the patient’s blood pressure below the current guidelines. Similarly, increasing the diuretic dose may have little effect on blood pressure levels, but it can increase the risk of side effects. Therefore, it is important to focus on non-pharmacological measures, such as reducing alcohol intake, to effectively manage hypertension. By taking these steps, patients can improve their overall health and reduce their risk of complications associated with high blood pressure.

Immediate hospital admission and prompt administration of corticosteroids are crucial in cases of giant cell arteritis accompanied by visual impairment. Delay in treatment can result in permanent loss of vision. Although there may be concerns about a possible transient ischemic attack or stroke, the patient’s medical history, physical examination, and laboratory results suggest a diagnosis of giant cell arteritis. Therefore, urgent CT of the head may not be necessary at this time.

Temporal arteritis is a type of large vessel vasculitis that often occurs in patients over the age of 60 and is commonly associated with polymyalgia rheumatica. This condition is characterized by changes in the affected artery that skip certain sections while damaging others. Symptoms of temporal arteritis include headache, jaw claudication, and visual disturbances, with anterior ischemic optic neuropathy being the most common ocular complication. A tender, palpable temporal artery is also often present, and around 50% of patients may experience symptoms of PMR, such as muscle aches and morning stiffness.

To diagnose temporal arteritis, doctors will typically look for elevated inflammatory markers, such as an ESR greater than 50 mm/hr or elevated CRP levels. A temporal artery biopsy may also be performed to confirm the diagnosis, with skip lesions often being present. Treatment for temporal arteritis involves urgent high-dose glucocorticoids, which should be given as soon as the diagnosis is suspected and before the temporal artery biopsy. If there is no visual loss, high-dose prednisolone is typically used, while IV methylprednisolone is usually given if there is evolving visual loss. Patients with visual symptoms should be seen by an ophthalmologist on the same day, as visual damage is often irreversible. Other treatments may include bone protection with bisphosphonates and low-dose aspirin, although the evidence supporting the latter is weak.